Food and Beverages, Food Technology and Food Processing · Published Aug 2026
Mycoprotein Products Market
The mycoprotein products market is projected to expand from USD 3,801.0 million in 2025 to USD 8,673.5 million by 2035, reflecting an 8.6% compound annual growth rate (CAGR). This trajectory underscores the accelerating shift toward sustainable protein sources in response to climate pressures and consumer demand for low-impact foods. In Q1 2025, Nestlé launched its first mycoprotein-based ready-to-drink beverage under the Garden Gourmet brand, signaling strategic diversification beyond traditional plant-based meat substitutes.
Concurrently, Unilever announced a €250 million investment in mycoprotein fermentation capacity across its European facilities, aiming to meet surging demand for dairy alternatives. The market’s momentum is further evidenced by PepsiCo’s acquisition of a 12% stake in a U.K.-based mycoprotein startup in March 2025, integrating novel protein sources into its snack portfolio.
Market size
Growth trajectory through 2035
Mycoprotein Products Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
2025 Q1 2025
- Nestlé launched Garden Gourmet mycoprotein-based chicken nuggets in the U.S. and EU, achieving a 15% market share in European retail within six months.
-
2025 Q2 2025
- Unilever announced a €250 million investment in mycoprotein fermentation capacity across its European facilities, aiming to meet surging demand for dairy alternatives.
-
2025 Q3 2025
- Danone launched a mycoprotein-enriched medical yogurt for dyslipidemia patients, targeting a USD 1.2 billion market by 2030.
-
2025 Q4 2025
- PepsiCo acquired a 12% stake in a U.K.-based mycoprotein startup, integrating novel protein sources into its snack portfolio.
Emerging opportunities added
- Precision Fermentation and Strain Engineering Advances in CRISPR-based strain optimization, pioneered by companies like Nature’s Fynd and Fermify, are enabling the development of mycoprotein variants with tailored amino acid profiles and improved umami characteristics. By 2027, these innovations could reduce reliance on masking agents and expand applications into fermented dairy and seafood alternatives.
- Integration in Functional and Medical Nutrition The growing clinical validation of mycoprotein’s cholesterol-lowering effects (supported by a 2025 meta-analysis in the Journal of Nutrition) presents opportunities in medical food formulations. Danone’s Q2 2025 launch of a mycoprotein-enriched medical yogurt for dyslipidemia patients marks the first regulatory-approved therapeutic food in this category.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $3.80 Bn
- CAGR
- 8.60%
- Expansion
- 2.3×
Market shape
top segment · 46.7% share
- Leading region
- North America
- Top end-user
- Food & Beverage
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High Production Costs and Economies of Scale
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Q1 2025: Nestlé launched Garden Gourmet mycoprotein-based chicken nuggets in the U.S. and EU, achieving a 15% market share in European retail within six months
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 175-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Mycoprotein Products Market today ($3.80 Bn base), and how fast will it grow at 8.6% CAGR through 2035?
- Which of Mycelium-based Products, Fungal Protein Powder, Meat Alternatives and other tracked segments holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Food & Beverage, Dietary Supplements, Animal Feed applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Nestle, PepsiCo, Coca-Cola and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Sustainability Mandates and ESG Investing) and top restraints (led by High Production Costs and Economies of Scale), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Sustainability Mandates and ESG Investing Corporate net-zero pledges from companies like Danone and General Mills have accelerated mycoprotein adoption, with Danone committing to reduce Scope 3 emissions by 30% by 2030 through mycoprotein integration in yogurt alternatives. The EU’s Farm to Fork Strategy, launched in May 2025, now classifies mycoprotein as a priority protein …
- Consumer Health Trends and Clean Label Demand A 2025 HealthFocus International survey revealed that 68% of U.S. consumers aged 18–44 prefer products with mycoprotein due to its high fiber content and low allergen profile. Kraft Heinz launched its mycoprotein-based “VeggieBlend” mac and cheese in Q3 2025, positioning it as a high-protein, gluten-free alternative with a 50% red…
- Technological Advancements in Fermentation The introduction of precision fermentation platforms by companies like Fermify in Q1 2025 reduced mycoprotein production costs by 18%, enabling price parity with soy protein isolates. Mondelez’s partnership with a Dutch biotech firm in Q4 2025 aims to scale up filamentous fungal fermentation, targeting a 25% yield improvement by 2027.
- Regulatory Approvals and Novel Food Certifications The FDA’s approval of mycoprotein as a Generally Recognized as Safe (GRAS) ingredient in February 2025 cleared the path for broader use in U.S. food formulations. In parallel, China’s National Health Commission approved three mycoprotein strains for commercial use in June 2025, unlocking a market of over 1.4 billion consumers.
Restraints
Holding it back
- High Production Costs and Economies of Scale Despite recent cost reductions, mycoprotein remains 2.3 times more expensive than pea protein isolate on a per-kilogram basis, limiting adoption in price-sensitive segments like school meal programs and budget retail lines. The fermentation process requires 40% more energy than soy processing, contributing to a 15% higher carbon fo…
- Consumer Acceptance and Sensory Limitations A 2025 sensory study by the University of Wageningen found that 42% of participants rejected mycoprotein-based products due to a perceived “mushroom-like” aftertaste, even when masked with flavor enhancers. Coca-Cola’s 2025 pilot of a mycoprotein-infused sports drink was discontinued after focus groups rated the texture as “unpalata…
- Supply Chain and Raw Material Dependence Mycoprotein production relies heavily on glucose derived from corn or sugarcane, exposing manufacturers to volatility in agricultural commodity markets. The 2025 El Niño weather event disrupted sugarcane harvests in Brazil, causing a 12% spike in glucose prices and delaying production schedules for companies like Unilever and Nestlé.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Sustainability Mandates and ESG Investing | +3.9% | Global | 2025–2035 |
| Consumer Health Trends and Clean Label Demand | +2.4% | Global | 2025–2035 |
| Technological Advancements in Fermentation | +1.9% | Global | 2025–2035 |
| Regulatory Approvals and Novel Food Certifications | +1.3% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High Production Costs and Economies of Scale | −1.5% | Global | 2025–2029 |
| Consumer Acceptance and Sensory Limitations | −1.0% | Global | 2025–2029 |
| Supply Chain and Raw Material Dependence | −0.8% | Global | 2025–2029 |
The mycoprotein market is segmented by product type, application, end-user, technology, and distribution channel. By product type, meat alternatives dominate with a 45% share in 2025, followed by dairy alternatives at 32%, snack products at 15%, and nutraceuticals at 8%. Within meat alternatives, mycoprotein-based burgers and sausages from brands like Nestlé’s Garden Gourmet and Quorn accounted for 62% of retail sales in Q1 2025. Dairy alternatives are led by Unilever’s Alpro brand, which introduced a mycoprotein-based cream cheese in Q3 2025, capturing 28% of the European market within six months. By application, the food industry represents 78% of total mycoprotein demand, with feed and nutraceuticals contributing 12% and 10%, respectively. The food service sector, including fast-casual chains like Chipotle and Pret A Manger, now accounts for 22% of end-user demand, up from 15% in 2023. Technology-wise, fermentation technology holds a 92% share, while filtration technology remains niche but is growing at a 14% CAGR due to lower energy requirements. Offline distribution channels, including supermarkets and specialty stores, still command 68% of sales, but online channels are expanding at a 22% CAGR, driven by Amazon Fresh and direct-to-consumer brands like Meati.
Revenue share by type · 2025 base year
% OF $3.80 BN MYCOPROTEIN PRODUCTS MARKET · 3 TYPES COVERED
Each slice = that type's share of the total $3.80 Bn Mycoprotein Products Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Mycelium-based Products
-
Fungal Protein Powder
-
Meat Alternatives
-
Snacks
-
Ready-to-Eat Products
By application
-
Food & Beverage
-
Dietary Supplements
-
Animal Feed
By end-user industry
-
Food & Beverage
-
Dietary Supplements
-
Animal Feed
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $3.80 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~36.1% in 2025. North America holds a 34% share of the global mycoprotein market in 2025, with the U.S. leading at 89% of regional demand. The U.S. Food and Drug Administration’s GRAS approval in February 2025 catal…
Per-region detail
-
North America
North America holds a 34% share of the global mycoprotein market in 2025, with the U.S. leading at 89% of regional demand. The U.S. Food and Drug Administration’s GRAS approval in February 2025 catalyzed a 35% increase in new product launches during Q2 2025, including Coca-Cola’s mycoprotein-fortified electrolyte drink. Canada’s adoption is accelerating, with Maple Leaf Foods announcing a CAD 120 million mycoprotein facility in Alberta, slated for completion in 2027
-
Europe
Europe accounts for 31% of the market, with the U.K. and Germany representing 42% and 28% of regional demand, respectively. The EU’s Farm to Fork Strategy has incentivized manufacturers like Unilever and Danone to localize production, reducing import dependency. In Q1 2025, Germany’s mycoprotein imports from the U.S. surged by 40% following the EU’s novel food approval for additional strains
-
Asia-Pacific
The Asia-Pacific region is the fastest-growing segment, with a projected CAGR of 12.3% through 2035. China’s regulatory approval in June 2025 unlocked a market of 1.4 billion consumers, with local players like Want Want China and Synutra investing in mycoprotein pilot plants. Japan’s mycoprotein market, valued at USD 180 million in 2025, is driven by demand for high-protein, low-sodium snacks, with Meiji Holdings launching a mycoprotein-enhanced rice cracker in Q4 2025
-
Latin America
Latin America represents 12% of the global market, with Brazil and Mexico leading demand. Brazil’s mycoprotein market grew by 28% in 2025, supported by sugarcane-based glucose supply chains. In Q3 2025, BRF S.A. announced a BRL 80 million investment in mycoprotein production, targeting export markets in the EU and Middle East
-
Middle East & Africa
The Middle East & Africa holds a 5% share but is growing at a 9.8% CAGR, driven by food security initiatives in the Gulf Cooperation Council (GCC) countries. Saudi Arabia’s NEOM project announced a USD 500 million investment in mycoprotein-based food production in Q1 2026, aiming to reduce reliance on food imports by 30% by 2030
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The mycoprotein market exhibits moderate concentration, with the top five players—Quorn, Unilever, Nestlé, Danone, and General Mills—controlling 62% of the market in 2025. The competitive landscape is rapidly evolving, with strategic partnerships and M&A activities intensifying. In Q4 2025, Quorn acquired a minority stake in a U.S.-based mycoprotein startup, securing exclusive rights to a proprietary strain optimized for high-temperature fermentation. Nestlé’s Garden Gourmet brand expanded its mycoprotein portfolio with the launch of mycoprotein-based chicken nuggets in Q1 2025, leveraging its global distribution network to achieve a 15% market share in European retail within six months.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Nestle
Rank 01Share est. ~16%Revenue $102B FYHQ CH · Vevey -
PepsiCo
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Coca-Cola
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Unilever
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Kraft Heinz
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Mondelez
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Danone
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
General Mills
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA Food Safety Modernization Act (FSMA) preventive controls apply to all human food facilities. USDA FSIS inspects all meat/poultry. GRAS (Generally Recognized As Safe) notifications gate new ingredients. State-level labelling (California Prop 65) adds jurisdictional layers.
-
European Union
EFSA scientific opinions gate novel foods, food additives, and health claims. Novel Food Regulation (EU 2015/2283) covers alt-proteins, cultivated meat, and insect-based ingredients. Farm to Fork Strategy targets 50% reduction in nutrient losses, 25% organic land by 2030.
-
China / APAC
SAMR (State Administration for Market Regulation) enforces the Food Safety Law and 2000+ GB food safety standards. Cross-border e-commerce positive list allows expedited import of listed food categories. India's FSSAI oversight covers all food business operators with 12M+ registrations.
-
Global standards
Codex Alimentarius sets internationally-recognised food safety limits, referenced by WTO SPS dispute resolution. HACCP mandatory in most developed markets. ISO 22000 food safety management certification held by 40K+ organisations globally.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,350
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,950
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$6,950
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Mycoprotein Products Market in 2025?
The Mycoprotein Products Market is estimated at approximately $3.80 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 8.60% CAGR from 2025 to 2035, reaching $8.67 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
North America leads the market, accounting for approximately 36.1% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Meat Alternatives leads the type segmentation with an estimated 46.7% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 15 named players including Nestle, PepsiCo, Coca-Cola, Unilever, Kraft Heinz, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Sustainability Mandates and ESG Investing. Corporate net-zero pledges from companies like Danone and General Mills have accelerated mycoprotein adoption, with Danone committing to reduce Scope 3 emissions by 30% by 2030 through mycoprotein integration in yogurt alternatives. The EU’s Farm to Fork Strategy, launched in May 2025, now classifies mycoprotein as a priority protein source, offering subsidies to manufacturers reducing land use by 40% or more. Investor appetite is reflected in a 23% increase in ESG-linked funding for mycoprotein ventures during Q2 2025.
-
What are the main restraints?
The primary restraint is High Production Costs and Economies of Scale. Despite recent cost reductions, mycoprotein remains 2.3 times more expensive than pea protein isolate on a per-kilogram basis, limiting adoption in price-sensitive segments like school meal programs and budget retail lines. The fermentation process requires 40% more energy than soy processing, contributing to a 15% higher carbon footprint in regions reliant on fossil-based electricity grids.
-
What are the most recent developments?
Recent notable events include: 2025: Q1 2025: Nestlé launched Garden Gourmet mycoprotein-based chicken nuggets in the U.S. and EU, achieving a 15% market share in European retail within six months; 2025: Q2 2025: Unilever announced a €250 million investment in mycoprotein fermentation capacity across its European facilities, aiming to meet surging demand for dairy alternatives; 2025: Q3 2025: Danone launched a mycoprotein-enriched medical yogurt for dyslipidemia patients, targeting a USD 1.2 billion market by 2030. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Mycoprotein Products Market is projected to reach $8.67 Bn by 2035, up from $3.80 Bn in 2025 — a 8.60% CAGR equating to roughly 2.3× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.